Assistant Professor, Medicine, Case Western Reserve University School of Medicine
Oncology
Dr. Timothy P. Spiro, MD
|
|
Give Review
Doctor Timothy P. Spiro, MD is an expert in the field of Oncology. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Top MD". Timothy P. Spiro is also a published doctor. He has 31 paper published. The most recent paper is: Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography. Timothy Spiro accepts Medicare payments and is listed with Medicare.gov.
Publications
- Pulmonary toxicities of tyrosine kinase inhibitors.
- Venous thromboembolism in patients with monoclonal gammopathy of undetermined significance.
- A renal mass in a patient with melanoma.
- 5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenoCarcinoma of the small bowel.
- Venous Thromboembolism in Lymphoma: How Effectively Are We Treating Patients?
- Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms?
- The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin Lymphoma.
- Cerebral nocardiosis in a patient with NHL treated with rituximab.
- Complete remission of metastatic Carcinoma of the prostate with bicalutamide withdrawal.
- Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanine.
- Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with Lymphomatous potential.
- Low-grade follicular Lymphoma of the small intestine: a challenge for management.
- Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.
- Phase I clinical and pharmacokinetic study of rebeccamycin Analog NSC 655649 given daily for five consecutive days.
- New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine Analogues to abrogate d...
- Management of cutaneous Lymphomas using a multidisciplinary approach.
- O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
- Simultaneous determination of O6-benzylguanine and 8-oxo-O6-benzylguanine in human plasma by reversed-phase high-performance liquid chromatography.
- Severe Acute graft-versus-host disease of conjunctivae after allogeneic blood progenitor cell infusion.
- In vitro migraton of Walker 256 carcinosarcoma cells: dependence on microtubule and microfilament function.
- Coexisting Paget''s Disease of bone and hyperparathyroidism.
- A randomized, comparative study of buserelin with DES/orchiectomy in the treatment of stage D2 prostatic Cancer patients.
- A case of carcinoid.
- The association of metabolic syndrome with triple-negative breast Cancer.
- Primary cutaneous large B-cell Lymphoma of the leg relapsing as cutaneous intravascular large B-cell Lymphoma.
- Sequential tumor biopsies in early phase clinical trials of antiCancer agents for pharmacodynamic evaluation.
- Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and Tumors of patients after treatment with O(6)-benzylguanine.
- Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase.
- Secondary myelodysplastic syndrome after hydroxychloroquine therapy.
- Pulmonary toxicities of biologics: a review.
Schools
University Of Western Australia Faculty Of Medicine
Hutt Hospital
Auckland Hospital University
University Ct
University Hosps Cleveland Case Western Res University
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
Case Western Reserve University - University Hospitals -
University of Connecticut -
University of Western Australia Faculty of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1144277898 | |
| NPPES Provider LastName | SPIRO | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 441115605 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 637.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 15.0 | |
| Percent Opioid Claims | 2.35 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144277898 |
| Last Name Of The Provider | SPIRO |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
Dr. Alberto J. Montero, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Henry B. Koon Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan B. LeGrand, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Joseph Gibbons, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Greg V. Manson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew Parchman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evi Stavrou, MD |
|
|
Dr. Wei Lin, MD
This Doctor is OpenDoctor Recommended.
|